Ernexa Therapeutics (ERNAW) Dividends Paid - Common (2016 - 2023)

Ernexa Therapeutics has reported Dividends Paid - Common for 8 years, with the latest figure at $8000.0 in Q4 2023.

• For the quarter ending Q4 2023, Dividends Paid - Common changed 0.0% year-over-year to $8000.0; the trailing twelve-month figure through Sep 2024 stood at $16000.0 (changed 0.0% YoY), and the FY2023 full-year result was $16000.0, changed 0.0% from the prior year.
• Dividends Paid - Common for Q4 2023 stood at $8000.0, roughly flat from $8000.0 in the prior quarter.
• The five-year high for Dividends Paid - Common was $8000.0 in Q4 2019, with the low at -$8000.0 in Q4 2020.
• Historically, Dividends Paid - Common has averaged $4800.0 across 5 years, with a median of $8000.0 in 2019.
• Annual changes were most pronounced in 2020 — Dividends Paid - Common sank 200.0% — and 2021, when it surged 200.0%.
• Ernexa Therapeutics' Dividends Paid - Common stood at $8000.0 in 2019, then slumped by 200.0% to -$8000.0 in 2020, then surged by 200.0% to $8000.0 in 2021, then changed by 0.0% to $8000.0 in 2022, then changed by 0.0% to $8000.0 in 2023.
• The last three Dividends Paid - Common figures came in at $8000.0 (Q4 2023), $8000.0 (Q4 2022), and $8000.0 (Q4 2021), per Business Quant data.